Mankind Pharma issues shares under employee stock option plan

Mankind Pharma Limited, listed on both the NSE and BSE, has allotted 29,742 equity shares through its Mankind Employee Stock Option Plan 2022. This allotment, approved by the nomination and remuneration committee on August 26, 2025, follows the exercise of options by eligible employees. Each share has a face value of Re. 1/- and was issued at an exercise price of Rs. 860.00/-, inclusive of a premium of Rs. 859.00/- per share.

The allotment increases the company's paid-up share capital from 41,27,28,748 equity shares to 41,27,58,490 equity shares. These new shares will rank pari-passu with the existing equity shares. The company noted that the details of this allotment comply with Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

This move underscores Mankind Pharma's commitment to employee incentives, aligning employee interests with the company's growth. The company reported the filing date of the statement referred to in regulation 10(b) as September 27, 2023.